BEST-CSP Benchmark Study of Polymorphs I and II of Sulfamerazine and the Perils of Polytype Polymorphs.
- DOI
- 10.1021/acs.cgd.5c01406
- Published
- 2026 Jan 7
- Container
- Crystal growth & design
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1021/acs.cgd.5c01406,
title = {BEST-CSP Benchmark Study of Polymorphs I and II of Sulfamerazine and the Perils of Polytype Polymorphs.},
author = {Wood WP and Arhangelskis M and Bartůňková E and Bernardes CES and Boese AD and Braun DE and Bučar DK and Butkiewicz H and Červinka C and Civalleri B and Couvrat N and de Ronde E and Donà L and Dračínský M and Firaha D and Fulem M and Geronia Ii R and Goncharova N and Gryl M and Hoja J and Hoser A and Krzeszczakowska J and List A and Lončarić I and Mladineo B and Nyman J and Olehovics E and Raimondo M and Rietveld IB and Rodrigues RIS and Russo L and Salvalaglio M and Sarraguça M and Šnajdr J and Štejfa V and Sun G and Tinnemans P and Whitfield PS and Yang Z and Zhang Y and Price SL},
year = {2026},
journal = {Crystal growth \& design},
doi = {10.1021/acs.cgd.5c01406},
url = {https://doi.org/10.1021/acs.cgd.5c01406}
}RIS
TY - JOUR TI - BEST-CSP Benchmark Study of Polymorphs I and II of Sulfamerazine and the Perils of Polytype Polymorphs. AU - Wood WP AU - Arhangelskis M AU - Bartůňková E AU - Bernardes CES AU - Boese AD AU - Braun DE AU - Bučar DK AU - Butkiewicz H AU - Červinka C AU - Civalleri B AU - Couvrat N AU - de Ronde E AU - Donà L AU - Dračínský M AU - Firaha D AU - Fulem M AU - Geronia Ii R AU - Goncharova N AU - Gryl M AU - Hoja J AU - Hoser A AU - Krzeszczakowska J AU - List A AU - Lončarić I AU - Mladineo B AU - Nyman J AU - Olehovics E AU - Raimondo M AU - Rietveld IB AU - Rodrigues RIS AU - Russo L AU - Salvalaglio M AU - Sarraguça M AU - Šnajdr J AU - Štejfa V AU - Sun G AU - Tinnemans P AU - Whitfield PS AU - Yang Z AU - Zhang Y AU - Price SL PY - 2026 JO - Crystal growth & design DO - 10.1021/acs.cgd.5c01406 UR - https://doi.org/10.1021/acs.cgd.5c01406 ER -
APA
WP, W., M, A., E, B., CES, B., AD, B., DE, B., DK, B., H, B., C, Č., B, C., N, C., E, D. R., L, D., M, D., D, F., M, F., R, G. I., N, G., M, G., J, H., A, H., J, K., A, L., I, L., B, M., J, N., E, O., M, R., IB, R., RIS, R., L, R., M, S., M, S., J, Š., V, Š., G, S., P, T., PS, W., Z, Y., Y, Z., & SL, P. (2026). BEST-CSP Benchmark Study of Polymorphs I and II of Sulfamerazine and the Perils of Polytype Polymorphs.. Crystal growth & design. https://doi.org/10.1021/acs.cgd.5c01406
Source records
- pubmed · retrieved 2026-09-25T20:43:01.855Z